| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | DHR Danaher CORP /de/ | Rales Mitchell P | Chairman Of Exec. Committee | Sell | 159,088 | $219.14 | $34,862,399.39 | -9.4% | -1.3% | - | |
| Nov 12, 2025 | MTD Mettler Toledo International Inc/ | Kaltenbach Patrick | President And CEO | Sell | 2,000 | $1,462.50 | $2,924,997.72 | -9.8% | - | - | |
| Nov 12, 2025 | CSTL Castle Biosciences INC | Juvenal Tobin W | Chief Commercial Officer | Sell | 700 | $35.39 | $24,775.00 | -0.4% | - | - | |
| Nov 11, 2025 | CSTL Castle Biosciences INC | Stokes Frank | Chief Financial Officer | Sell | 5,388 | $35.08 | $189,011.04 | -11.1% | - | - | |
| Nov 11, 2025 | CSTL Castle Biosciences INC | Oelschlager Kristen M | Chief Operating Officer | Sell | 18,932 | $35.10 | $664,513.20 | -60.6% | - | - | |
| Nov 11, 2025 | DHR Danaher CORP /de/ | McGrew Matthew | EVP &Chief Financial Officer | Sell | 16,172 | $214.62 | $3,470,831.41 | -44.6% | +0.4% | - | |
| Nov 11, 2025 | MEDP Medpace Holdings, INC. | Burwig Susan E | Exec. VP, Operations | Sell | 18,000 | $605.00 | $10,890,000.00 | -27.5% | - | - | |
| Nov 11, 2025 | MTD Mettler Toledo International Inc/ | Vadala Shawn | Chief Financial Officer | Sell | 1,895 | $1,455.52 | $2,758,212.45 | -15.1% | - | - | |
| Nov 11, 2025 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc | Head Of Eur &Na Market Orgs | Sell | 6,880 | $1,450.00 | $9,976,000.00 | -97.4% | - | - | |
| Nov 11, 2025 | NTRA Natera, INC. | Sheena Jonathan | Director, Co-founder | Sell | 1,500 | $207.96 | $311,933.77 | -1.0% | - | - | |
| Nov 10, 2025 | BDSX Biodesix INC | Vazquez Chris | Chief Accounting Officer | Sell | 13 | $7.62 | $99.06 | -1.4% | - | - | |
| Nov 10, 2025 | BDSX Biodesix INC | Pestano Gary Anthony | Chief Development Officer | Sell | 23 | $7.62 | $175.26 | -0.3% | - | - | |
| Nov 10, 2025 | TMO Thermo Fisher Scientific INC. | Pettiti Gianluca | Executive Vice President | Sell | 2,975 | $580.00 | $1,725,500.00 | -6.6% | -5.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.